Immunological activation of human umbilical cord blood mast cells induces tryptase secretion and interleukin-6, and histidine decarboxilase mRNA gene expression

Pharmacological Research

Volumn 55, Issue 1, 2007, Pages 57-63

  Castellani, M L ^a   Perrella, A ^b   Kempuraj, D J ^c   Boucher, W ^c   Tagen, M ^c   Salini, V ^a   Vecchiet, J ^a   Tete S ^a   Frydas, S ^d   Theoharides, T C ^c   Conti, P ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Histidine decarboxylase; Human umbilical cord blood mast cells; IL 6; Inflammation; Tryptase

Indexed keywords

HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 6; MESSENGER RNA; TRYPTASE;

ALLERGIC DISEASE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY DISEASE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL BLOOD; HISTAMINE RELEASE; HISTIDINE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-6; MAST CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRYPTASES;

EID: 33846289573     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.10.006     Document Type: Article

References (46)

1. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., et al. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89 (1997) 4120-4127
2. Conti P., Reale M., Barbacane R.C., Letourneau R., and Theoharides T.C. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice. FASEB J 12 (1998) 1693-1700
3. Kempuraj D., Saito H., Kaneko A., Fukagawa K., Nakayama M., Toru H., et al. Characterization of mast cell committed progenitors present in human umbilical cord blood. Blood 93 (1999) 3338-3346
4. Kandere-Grzybowska K., Letourneau R., Kempuraj D., Donelan J., Poplawski S., Boucher W., et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 171 9 (2003) 4830-4836
5. Petrarca C., Frydas S., Donelan J., Boucher W., Papadopoulou N., Cao J., et al. Interleukin 27 (IL-27): a novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int J Immunopathol Pharmacol 18 (2005) 191-194
6. Deambrosis I., Scalabrino E., Deregibus M.C., Camusi G., and Bussolati B. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway inhibits apoptosis of human cultured mesangial cells induced by oxidized LDL. Int J Immunopathol Pharmacol 18 (2005) 327-338
7. Cavalieri B., Mosca M., Ramadori P., Perrelli M.-G., De Simone L., Colotta F., et al. Neutrophil recruitment in the reperfused-injured rat liver was effectivelyattenuated by repertaxin, a novelallosteric noncompetitive inhibitor of CXCL8 receptors: atherapeutic approach for the treatment of post-ischemic hepatic syndromes. Int J Immunopathol Pharmacol 18 (2005) 475-486
8. Carinci F., Lo Muzio L., Piattelli A., Rubini C., Chiesa F., Ionna F., et al. Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol 18 (2005) 513-524
9. Liu Q., and Hamblin M.R. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state. Int J Immunopathol Pharmacol 18 (2005) 391-402
10. D'Haene N., Maris C., Sandras F., Dehou M.-F., Remmelink M., Decaestecker C., et al. The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. Int J Immunopathol Pharmacol 18 (2005) 431-443
11. Cipollone F., Chiarelli F., Iezzi A., Fazia M.L., Cuccurullo C., Pini B., et al. Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. Int J Immunopathol Pharmacol 18 (2005) 625-636
12. Musso T., Cappello P., Stornello S., Ravarino D., Caorsi C., Otero K., et al. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. Int J Immunopathol Pharmacol 18 (2005) 339-350
13. Vecchiet J., Dalessandro M., Travasi F., Falasca K., Di Iorio A., Schiavone C., et al. Interleukin-4 and Interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int J Immunopathol Pharmacol 16 (2003) 33-41
14. Lesma E., Riva E., Giovannini M., Di Giulio A.M., and Gorio A. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. Int J Immunopathol Pharmacol 18 (2005) 297-308
15. Serafin W.E., and Austen K.F. Mediators of immediate hypersensitivity reactions. N Engl J Med 317 1 (1987) 30-34
16. Totaro R., Passacantando A., Russo T., Parzanese I., Rascente M., Marini C., et al. Effects of interferon beta, cyclophosphamide, and azathioprine on cytokine profile in patients with multiple sclerosis. Int J Immunopathol Pharmacol 18 (2005) 377-384
17. Carmignani M., Zucchetti F., Sacco R., Bolognini S., and Volpe A.R. Shock induction by arterial hypoperfusion of the gut involves synergistic interactions between the peripheral enkephalin and nitric oxide systems. Int J Immunopathol Pharmacol 18 (2005) 33-48
18. Bonsi L., Pierdomenico L., Biscardi M., Marchionni C., Gavazzi S., Fossati V., et al. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathway. Int J Immunopathol Pharmacol 18 (2005) 445-455
19. Licastro F., Chiappelli M., Ruscica M., Carnelli V., and Corsi M.M. Altered cytokine and acute phase response protein levels in the blood of children with downs syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 18 (2005) 165-172
20. Gioia C., Horejsh D., Agrati C., Martini F., Capobianchi M.R., Ippolito G., et al. T-Cell response profiling to biological threat agents including the SARS coronavirus. Int J Immunopathol Pharmacol 18 (2005) 525-530
21. Matalon R., Surendran S., McDonald J.D., Okorodudu A.O., Tyring S.K., Michals-Matalon K., et al. Abnormal expression of genes associated with development and inflammation in the heart of mouse maternal phenylketonuria offspring. Int J Immunopathol Pharmacol 18 (2005) 557-565
22. Avgerinos D.V., and Theoharides T.C. Mesenteric traction syndrome or gut in distress. Int J Immunopathol Pharmacol 18 (2005) 195-200
23. Marinova S., Nenkov P., Markova R., Nikolaeva S., Kostadinova R., Mitov I., et al. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int J Immunopathol Pharmacol 18 (2005) 457-473
24. Benyon R.C., Robinson C., and Church M.K. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 97 3 (1989, Jul) 898-904
25. Dvorak A.M., MacGlashan Jr. D.W., Morgan E.S., and Lichtenstein L.M. Vesicular transport of histamine in stimulated human basophils. Blood 88 11 (1996) 4090-4101
26. Gambi F., De Berardis D., Sepede G., Quartesan R., Calcagni E., Salerno R.M., et al. Cannabinoid receptors and their relationships with neuropsychiatric disorders. Int J Immunopathol Pharmacol 18 (2005) 15-20
27. Appert-Collin A., Duong F.H.T., Passilly Degrace P., Bennasroune A., Poindron P., Warter J.-M., et al. Xaliproden (SR57746A) induces 5-HT1A receptors-mediated map kinase activation in PC12 cells. Int J Immunopathol Pharmacol 18 (2005) 233-244
28. Leggio L., Addolorato G., Abenavoli L., and Gasbarrini G. Wilson's disease: clinical, genetic and pharmacological findings. Int J Immunopathol Pharmacol 18 (2005) 7-14
29. Riccioni G., Di Pietro V., Staniscia T., De Feudis L., Traisci G., Capani F., et al. Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. Int J Immunopathol Pharmacol 18 (2005) 575-586
30. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: distinct toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170 4 (2003) 1625-1629
31. Montalto M., Santoro L., Vastola M., Curigliano V., Ricci R., Vecchio F.M., et al. Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment. Int J Immunopathol Pharmacol 18 (2005) 603-608
32. Trubiani O., Di Primio R., Traini T., Pizzicannella J., Scarano A., Piattelli A., et al. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament. Int J Immunopathol Pharmacol 18 (2005) 213-222
33. Lanzilli G., Falchetti R., Tricarico M., Ungheri D., and Fuggetta M.P. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol 18 (2005) 245-254
34. Artese L., Ucchino S., Piattelli A., Piccirilli M., Perrotti V., Mezzetti A., et al. Factors associated with apoptosis in symptomatic and asymptomatic carotid atherosclerotic plaques. Int J Immunopathol Pharmacol 18 (2005) 645-654
35. Theoharides T.C., Patra P., Boucher W., Letourneau R., Kempuraj D., Chiang G., et al. Chondroitin sulphate inhibits connective tissue mast cells. Br J Pharmacol 131 6 (2000) 1039-1049
36. Huang S.H., Frydas S., Conti P., Kempuraj D., Barbacane R.C., Grilli A., et al. Interleukin-17: a revisited study. Int J Immunopathol Pharmacol 17 (2004) 1-8
37. Cavalieri S., Rotoli M., Feliciani C., and Amerio P. Expression of the high-affinity laminin receptor (67 kDa) in normal human skin and appendages. Int J Immunopathol Pharmacol 18 (2005) 223-232
38. Kempuraj D., Frydas S., Karagouni E., Hatzistilianou M., Boscolo P., Ferro F., et al. Cytokines and the brain. Int J Immunopathol Pharmacol 17 (2004) 229-232
39. Trubiani O., Di Primio R., Traini T., Pizzicannella J., Scarano A., Piattelli A., et al. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament. Int J Immunopathol Pharmacol 18 (2005) 213-222
40. Pannellini T., Iezzi M., Di Carlo E., Eleuterio E., Coletti A., Modesti A., et al. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int J Immunopathol Pharmacol 17 (2004) 171-180
41. Yamaki K., Uchida H., Li X., Yanagisawa R., Takano H., Hayashi H., et al. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int J Immunopathol Pharmacol 18 (2005) 133-144
42. Galli S.J. New concepts about the mast cell. N Engl J Med 328 4 (1993) 257-265
43. neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in her-2/neu transgenic mice. Int J Immunopathol Pharmacol 18 (2005) 351-364
44. Alexandrakis M.G., Passam F.H., Pappa C.A., Damilakis J., Tsirakis G., Kandidaki E., Stathopoulos E.N., and Kyriakou D.S. Serum evaluation of angiogenic cytokines basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density. Int J Immunopathol Pharmacol 18 (2005) 287-296
45. Rossi R.E., and Monasterolo G. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 18 (2005) 277-286
46. Ridolo E., Albertini R., Borghi L., Meschi T., Montanari E., and Dall'Aglio Pp. Acute polyradiculoneuropathy occurring after hymenoptera stings: a clinical case study. Int J Immunopathol Pharmacol 18 (2005) 385-390